Quick Takeaways
- Kevin F. Mclaughlin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $648,365.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Kevin F. Mclaughlin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VCEL | Vericel Corp | Director | $523,365 | -$1,044,050 | -67% | 11 Feb 2026 |
| IVVD | Invivyd, Inc. | Director | $125,000 | +$125,000 | +100% | 19 Nov 2025 |
| XLRN | ACCELERON PHARMA INC | SVP, CFO and Treasurer | 19 Nov 2021 | |||
| DBTX | Decibel Therapeutics, Inc. | Director | 25 Sep 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|